Top

Supportive Care in Cancer

Published in:

01-09-2011 | Original Article

Individualized pharmacological treatment of oral mucositis pain in patients with head and neck cancer receiving radiotherapy

Authors: Ingrid Stenstrom Ling, Britt Larsson

Published in: Supportive Care in Cancer | Issue 9/2011

Abstract

Purpose

Pain is a prominent symptom in radiotherapy-induced oral mucositis (OM). This study assesses the effect of pharmacological treatment in head and neck cancer patients with OM-induced pain and swallowing difficulties.

Methods

This study included 82 patients with head and neck cancer undergoing radiotherapy and referred to the Pain and Rehabilitation Centre at Linkoping University Hospital in Sweden because of OM-induced pain. During 1 week, pain assessment, onset of individually tailored choice of drugs, treatment evaluation, and adjustments, were undertaken. Combinations of acetaminophen, non-steroid anti-inflammatory drug (NSAID), and opioids were by steps applied. To evaluate effects, the patients answered the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-head and neck 35 in connection with the initial pain assessment and 1 week later.

Results

Worsening of soreness in mouth and overall worsening of swallowing difficulties were seen in the patients referred within the third week of radiotherapy, showing increased severity of OM during the current week (n = 59). Pain and swallowing difficulties were unchanged in patients referred later than the third week, showing unchanged severity of OM during the current week (n = 23).

Conclusion

The answers to the questionnaire showed that the individualized pain treatment with systemic analgesics exploited to the highest degree was insufficient. Future development of pharmacological possibilities for treatment of OM-related pain is urgent. In addition, development of structured nursing care and patient self-care can contribute to improved pain relief.

Argiris A, Karamouzis MV, Raben D, Ferris RL (2008) Head and neck cancer. Lancet 371:1695–1709PubMedCrossRef

Scully C, Bagan J (2009) Oral squamous cell carcinoma overview. Oral Oncol 45:301–308. doi:10.1016/j.oraloncology.2009.01.004 PubMedCrossRef

Epstein JB, Elad S, Eliav E, Jurevic R, Benoliel R (2007) Orofacial pain in cancer: part II—clinical perspectives and management. J Dent Res 86(6):506–518. doi:10.1177/154405910708600605 PubMedCrossRef

Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, Komaroff E, Nalysnyk L, Zilberberg M (2003) Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66(3):253–262. doi:10.1016/S0167-8140(02)00404-8 PubMedCrossRef

Lalla RV, Sonis ST, Peterson DE (2008) Management of oral mucositis in patients with cancer. Dent Clin North Am 52(1):61–77, viiiPubMedCrossRef

Scully C, Sonis S, Diz PD (2006) Oral mucositis. Oral Dis 12(3):229–241. doi:10.1111/j.1601-0825.2006.01258.x PubMedCrossRef

Sonis ST, Elting LS, Keefe D et al (2004) Perspectives on cancer therapy-inducedmucosal injury, pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100(9 Suppl):1995–2025. doi:10.1002/cncr.20162 PubMedCrossRef

Treister N, Sonis S (2007) Mucositis: biology and management. Curr Opin Otolaryngol Head Neck Surg 15:123–129PubMedCrossRef

Napenas JJ, Shetty KV, Streckfus CF (2007) Oral mucositis: review of pathogenesis, diagnosis, prevention and management. Gen Dent 55(4):335–344PubMed

10.

Elting LS, Cooksley CD, Chambers MS, Garden AS (2007) Risk, outcomes and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys 68(4):1110–1120. doi:10.1016/j.ijrobp.2007.01.053 PubMedCrossRef

11.

Benoliel R, Epstein J, Eliav E, Jurevic R, Elad S (2007) Orofacial pain in cancer: part I—mechanisms. J Dent Res 86(6):491–505. doi:10.1177/154405910708600604 PubMedCrossRef

12.

Rosenthal DI, Trotti A (2009) Strategies for managing radiation-induced mucositis in head and neck cancer. Semin Radiat Oncol 19:29–34. doi:10.1016/j.semradonc.2008.09.006 PubMedCrossRef

13.

Raykher A, Russo L, Schattner M et al (2007) Enteral nutrition support of head and neck cancer patients. Nutr Clin Pract 22(1):68–73. doi:10.1177/011542650702200168 PubMedCrossRef

14.

Rubenstein EB, Peterson DE, Schubert M et al (2004) Clinical practice guidelines for the prevention and treatment of cancer therapy–induced oral and gastrointestinal mucositis. Cancer 100(9):2026–2046. doi:10.1002/cncr.20163 PubMedCrossRef

15.

Silverman S (2007) Diagnosis and management of oral mucositis. J Support Oncol 5(2, Suppl 1):13–21PubMed

16.

Russo G, Haddad R, Posner M, Machtay M (2008) Radiation treatment breaks and ulcerative mucositis in head and neck cancer. Oncologist 13(8):886–898. doi:10.1634/theoncologist.2008-0024 PubMedCrossRef

17.

Bensinger W, Schubert M, Ang K-K, Brizel D, Brown E, Eilers J, Elting L, Mittal B, Schattner M, Spielberger R, Treister N, Trotti A (2008) NCCN task force report. Prevention and management of mucositis in cancer care. J Natl Comp Cancer Netw 6(Suppl 1):S1–S21, quiz S22–4

18.

Laird B, Colvin L, Fallon M (2008) Management of cancer pain: basic principles and neuropathic cancer pain. Eur J Cancer 44(8):1078–1082. doi:10.1016/j.ejca.2008.03.022 PubMedCrossRef

19.

Bennett MI, Attal N, Backonja M, Baron R, Bouhassira D, Freynhagen R, Scholz J, Tölle TR, Wittchen H-U, Staehelin Jensen T (2007) Using screening tools to identify neuropathic pain. Pain 127(3):199–203. doi:10.1016/j.pain.2006.10.034 PubMedCrossRef

20.

Fainsinger RL, Fairchild A, Nekolaichuk C, Lawlor P, Lowe S, Hanson J (2009) Is pain intensity a predictor of the complexity of cancer pain management? J Clin Oncol 27(4):585–590. doi:10.1200/JCO.2008.17.1660 PubMedCrossRef

21.

World Health Organization (1979) Handbook for reporting results of cancer treatment. Geneva, Switzerland, pp 15–22

22.

Bjordal K, Hammerlid E, Ahlner-Elmqvist M et al (1999) Quality of life in head and neck cancer patients: validation of the European organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol 17(3):1008–1019PubMed

23.

Sherman AC, Simonton S, Adams DC et al (2000) Assessing quality of life in patients with head and neck cancer: cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck module (QLQ-H&N35). Arch Otolaryngol Head Neck Surg 126(4):459–467PubMed

24.

Murphy B, MD BJ, Isitt J, Garden AS, Gwede CK, Trotti AM, Meridith RF, Epstein JB, Le Q-T, Brizel DM, Bellm LA, Wells N, Cella D (2009) Mucositis-related morbidity and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapy. J Pain Symptom Manage 38(4):522–532. doi:10.1016/j.jpainsymman.2008.12.004 PubMedCrossRef

25.

Epstein JB, Wilkie DJ, Fischer DJ, Kim Y, Villines D (2009) Neuropathic and nociceptive pain in head and neck cancer patients receiving radiation therapy. Head Neck Oncol 26(1):1–12. doi:10.1186/1758-3284-1-26, 1

26.

Wong PC, Dodd MJ, Miaskowski C, Paul SM, Bank KA, Shiba GH, Facione N (2006) Mucositis pain induced by radiation therapy: prevalence, severity, and use of self-care behaviours. J Pain Symptom Manage 32(1):27–37. doi:10.1016/j.jpainsymman.2005.12.020 PubMedCrossRef

27.

Bar Ad V, Weinstein G, Dutta PR, Chalian A, Both S, Quon H (2009) Gabapentin for the treatment of pain related to radiation-induced mucositis in patients with head and neck tumors treated with intensity-modulated radiation therapy. Head Neck 32(2):173–177. doi:10:1002/hed.21165

28.

Raykher A, Correa L, Russo L et al (2009) The role of pretreatment percutaneous endoscopic gastrostomy in facilitating therapy of head and neck cancer and optimizing the body mass index of the obese patient. J Parenter Enteral Nutr 33(4):404–410. doi:10.1177/0148607108327525 CrossRef

29.

McGuire DB, Correa ME, Johnson J, Wienandts P (2006) The role of basic oral care and good clinical practice principles in the management of oral mucositis. Support Care Cancer 14:541–547. doi:10.1007/s00520-006-0051-8 PubMedCrossRef

30.

Harris D, Eilers J, Harriman A et al (2008) Putting evidence into practice: evidence-based interventions for the management of oral mucositis. Clin J Oncol Nurs 12(1):141–152. doi:10.1188/08.CJON.141-152 PubMedCrossRef

31.

Armstrong JA, McCaffrey R (2005) The effects of mucositis on quality of life in patients with head and neck cancer. Clin J Oncol Nurs 10(1):53–56. doi:10.1188/06.CJON.53-56 CrossRef

32.

Wells M, Donnan PT, Sharp L et al (2008) A study to evaluate nurse-led on-treatment review for patients undergoing radiotherapy for head and neck cancer. J Clin Nurs 17(11):1428–1439. doi:10.1111/j.1365-2702.2007.01976.x PubMedCrossRef

Title: Individualized pharmacological treatment of oral mucositis pain in patients with head and neck cancer receiving radiotherapy
Authors: Ingrid Stenstrom Ling
Britt Larsson
Publication date: 01-09-2011
Publisher: Springer-Verlag
Published in: Supportive Care in Cancer / Issue 9/2011
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-010-0955-1

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 9/2011

Animal models of the cancer anorexia–cachexia syndrome

Self-reported fatigue: one dimension or more? Lessons from the Functional Assessment of Chronic Illness Therapy—Fatigue (FACIT-F) questionnaire

Exploring cancer support needs for older African-American men with prostate cancer

Is education an effective management strategy for reducing cancer-related fatigue?

Depression, mood, stress, and Th1/Th2 immune balance in primary breast cancer patients undergoing classical massage therapy

Oral symptoms and functional outcome related to oral and oropharyngeal cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer